Company Search:
Advanced Search
Sponsored Links
BioNexus Gene Lab Corp Company Snapshot
BioNexus Gene Lab Corp operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares BioNexus Gene Lab Corp with three other companies in this sector in UNITED STATES : Sesen Bio Inc (2020 sales of $11.24 million of which 100% was Protein Therapeutics), Urogen Pharma Ltd ($11.80 million of which 100% was Biopharmaceutical), and Viela Bio Inc ($11.65 million of which 100% was Pharmaceutical).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
BioNexus Gene Lab Corp
  Stock Performance Chart for BioNexus Gene Lab Corp
  Stock Data: Recent Stock Performance:
  Current Price (6/4/2021): 1.92
(Figures in U.S. Dollars)
1 Week 60.0%   13 Weeks 3.8%  
4 Weeks 9.7%   52 Weeks n/a  
BioNexus Gene Lab Corp Key Data:
  Ticker: BGLC Country: Malaysia
  Exchanges: OTC Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2020 Sales 11,390,440
(Year Ending Jan 2021).
Employees: 9
  Currency: U.S. Dollars Market Cap: 328,738,852
  Fiscal Yr Ends: December Shares Outstanding: 171,218,152
  Share Type: Common Closely Held Shares: N/A
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.